CD206+ tumor-associated macrophages interact with CD4+ tumor-infiltrating lymphocytes and predict adverse patient outcome in human laryngeal squamous cell carcinoma. This evidence concerns the gene MRC1 and laryngeal squamous cell carcinoma.